-

Agilent Wins Trade Secret and Patent Infringement Litigation

J&X Technologies to pay Agilent more than $1.25 million in damages for “willful and malicious” theft of Agilent trade secrets

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has won a judgement in federal court for patent infringement and trade secret misappropriation against Shanghai-based J&X Technologies. The court victory in the Northern District of Texas, Dallas Division, requires J&X to pay Agilent more than $1.25 million for illegally using Agilent patents and trade secrets in developing gas chromatography equipment.

The court victory also prevents J&X and its founders Xiaosheng Guan and Qiang Xu from manufacturing, distributing, or selling products using Agilent proprietary gas chromatography information. In addition, J&X is prohibited from disclosing or using Agilent gas chromatography information or other proprietary information. In its ruling, the Court noted that “J&X’s misappropriation of Agilent’s trade secrets was willful and malicious.”

“This court victory reinforces the critical importance Agilent places on protecting our intellectual property,” said Mike Tang, Agilent senior vice president and general counsel. “Innovation is central to what Agilent is all about and this court decision should stand as a message to those seeking to undermine our focus on innovation. We will always seek to protect our proprietary technology and the hard work of Agilent employees developing it to serve our customers.”

Gas chromatography is an analytical technique used to separate the chemical components of a sample mixture. It is used to detect what is in the mixture and how much of a given element or compound is present. Typical uses of gas chromatography include testing the purity of a particular substance or separating the different components of a mixture to understand how it is constituted.

Agilent has long been a leader in developing gas chromatography equipment. The company welcomes competition on its merits and looks forward to continuing to drive innovation in all areas of its business.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Contacts

Tom Beermann
+1 408-386-5892
tom.beermann@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Summary
Agilent wins trade secret and patent Infringement ruling; J&X Technologies to pay Agilent more than $1.25 million in damages.
Release Versions
$Cashtags

Contacts

Tom Beermann
+1 408-386-5892
tom.beermann@agilent.com

More News From Agilent Technologies Inc.

Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence

SANTA CLARA, Calif. & PHILADELPHIA--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones. Proscia is a leading independent provider of enterprise digital pathology software, serving...

Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time...

Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis. Developed for use with compatible Agilent BioTek automated imaging systems, the module uses AI-based segmentation without requiring conventional threshold setting or parameter tuning. By incorporating the...
Back to Newsroom